Report Detail

Request for Sample of this report

Other Global Biomarker of Disease Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4587290
    • |
  • 21 May, 2024
    • |
  • Global
    • |
  • 81 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

Omics, proteomics, meta-bolomics technologies are used in biomarkers discovery and disease diagnosis. Biomarkers are used in risk assessment, molecular diagnostic, disease diagnosis, DNA fingerprinting and other molecular applications. Biomarkers enable pharmaceutical companies to analyze and discover novel drugs as demand for cost effective and efficient treatment dose is increasing. Biomarkers are used in drug validation and testing, sample preparation and assay development to eliminate complexity in discovery and development of novel drugs. Biomarkers of disease are used in identification of disease condition and also help in validation of clinical trials for novel drug.
According to our (Global Info Research) latest study, the global Biomarker of Disease market size was valued at US$ 28550 million in 2023 and is forecast to a readjusted size of USD 79120 million by 2030 with a CAGR of 15.5% during review period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report is a detailed and comprehensive analysis for global Biomarker of Disease market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Biomarker of Disease market size and forecasts, in consumption value ($ Million), 2019-2030
Global Biomarker of Disease market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Biomarker of Disease market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Biomarker of Disease market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biomarker of Disease
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biomarker of Disease market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aushon Biosystem, Bio-Rad Laboratories, Thermo Fisher Scientific Inc, Siemens AG, Eisai Co. Ltd, Roche Diagnostics Limited, Abbott Laboratories, Inc, Epistem Ltd, Ge Healthcare, Agilent Technologies Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Biomarker of Disease market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Biomarker of Disease market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sample Preparation
Assay Development
Biomarker Validation and Testing
Others
Market segment by Application
Pharmaceutical Companies
Government & Private Research Institutes
Academic Institutes
Medical Device Manufacturing Companies
Others
Market segment by players, this report covers
Aushon Biosystem
Bio-Rad Laboratories
Thermo Fisher Scientific Inc
Siemens AG
Eisai Co. Ltd
Roche Diagnostics Limited
Abbott Laboratories, Inc
Epistem Ltd
Ge Healthcare
Agilent Technologies Inc
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biomarker of Disease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biomarker of Disease, with revenue, gross margin, and global market share of Biomarker of Disease from 2019 to 2024.
Chapter 3, the Biomarker of Disease competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Biomarker of Disease market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biomarker of Disease.
Chapter 13, to describe Biomarker of Disease research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Biomarker of Disease by Type
    • 1.3.1 Overview: Global Biomarker of Disease Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Biomarker of Disease Consumption Value Market Share by Type in 2023
    • 1.3.3 Sample Preparation
    • 1.3.4 Assay Development
    • 1.3.5 Biomarker Validation and Testing
    • 1.3.6 Others
  • 1.4 Global Biomarker of Disease Market by Application
    • 1.4.1 Overview: Global Biomarker of Disease Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Pharmaceutical Companies
    • 1.4.3 Government & Private Research Institutes
    • 1.4.4 Academic Institutes
    • 1.4.5 Medical Device Manufacturing Companies
    • 1.4.6 Others
  • 1.5 Global Biomarker of Disease Market Size & Forecast
  • 1.6 Global Biomarker of Disease Market Size and Forecast by Region
    • 1.6.1 Global Biomarker of Disease Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Biomarker of Disease Market Size by Region, (2019-2030)
    • 1.6.3 North America Biomarker of Disease Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Biomarker of Disease Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Biomarker of Disease Market Size and Prospect (2019-2030)
    • 1.6.6 South America Biomarker of Disease Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Biomarker of Disease Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Aushon Biosystem
    • 2.1.1 Aushon Biosystem Details
    • 2.1.2 Aushon Biosystem Major Business
    • 2.1.3 Aushon Biosystem Biomarker of Disease Product and Solutions
    • 2.1.4 Aushon Biosystem Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Aushon Biosystem Recent Developments and Future Plans
  • 2.2 Bio-Rad Laboratories
    • 2.2.1 Bio-Rad Laboratories Details
    • 2.2.2 Bio-Rad Laboratories Major Business
    • 2.2.3 Bio-Rad Laboratories Biomarker of Disease Product and Solutions
    • 2.2.4 Bio-Rad Laboratories Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Bio-Rad Laboratories Recent Developments and Future Plans
  • 2.3 Thermo Fisher Scientific Inc
    • 2.3.1 Thermo Fisher Scientific Inc Details
    • 2.3.2 Thermo Fisher Scientific Inc Major Business
    • 2.3.3 Thermo Fisher Scientific Inc Biomarker of Disease Product and Solutions
    • 2.3.4 Thermo Fisher Scientific Inc Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Thermo Fisher Scientific Inc Recent Developments and Future Plans
  • 2.4 Siemens AG
    • 2.4.1 Siemens AG Details
    • 2.4.2 Siemens AG Major Business
    • 2.4.3 Siemens AG Biomarker of Disease Product and Solutions
    • 2.4.4 Siemens AG Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Siemens AG Recent Developments and Future Plans
  • 2.5 Eisai Co. Ltd
    • 2.5.1 Eisai Co. Ltd Details
    • 2.5.2 Eisai Co. Ltd Major Business
    • 2.5.3 Eisai Co. Ltd Biomarker of Disease Product and Solutions
    • 2.5.4 Eisai Co. Ltd Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Eisai Co. Ltd Recent Developments and Future Plans
  • 2.6 Roche Diagnostics Limited
    • 2.6.1 Roche Diagnostics Limited Details
    • 2.6.2 Roche Diagnostics Limited Major Business
    • 2.6.3 Roche Diagnostics Limited Biomarker of Disease Product and Solutions
    • 2.6.4 Roche Diagnostics Limited Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Roche Diagnostics Limited Recent Developments and Future Plans
  • 2.7 Abbott Laboratories, Inc
    • 2.7.1 Abbott Laboratories, Inc Details
    • 2.7.2 Abbott Laboratories, Inc Major Business
    • 2.7.3 Abbott Laboratories, Inc Biomarker of Disease Product and Solutions
    • 2.7.4 Abbott Laboratories, Inc Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Abbott Laboratories, Inc Recent Developments and Future Plans
  • 2.8 Epistem Ltd
    • 2.8.1 Epistem Ltd Details
    • 2.8.2 Epistem Ltd Major Business
    • 2.8.3 Epistem Ltd Biomarker of Disease Product and Solutions
    • 2.8.4 Epistem Ltd Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Epistem Ltd Recent Developments and Future Plans
  • 2.9 Ge Healthcare
    • 2.9.1 Ge Healthcare Details
    • 2.9.2 Ge Healthcare Major Business
    • 2.9.3 Ge Healthcare Biomarker of Disease Product and Solutions
    • 2.9.4 Ge Healthcare Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Ge Healthcare Recent Developments and Future Plans
  • 2.10 Agilent Technologies Inc
    • 2.10.1 Agilent Technologies Inc Details
    • 2.10.2 Agilent Technologies Inc Major Business
    • 2.10.3 Agilent Technologies Inc Biomarker of Disease Product and Solutions
    • 2.10.4 Agilent Technologies Inc Biomarker of Disease Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Agilent Technologies Inc Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Biomarker of Disease Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Biomarker of Disease by Company Revenue
    • 3.2.2 Top 3 Biomarker of Disease Players Market Share in 2023
    • 3.2.3 Top 6 Biomarker of Disease Players Market Share in 2023
  • 3.3 Biomarker of Disease Market: Overall Company Footprint Analysis
    • 3.3.1 Biomarker of Disease Market: Region Footprint
    • 3.3.2 Biomarker of Disease Market: Company Product Type Footprint
    • 3.3.3 Biomarker of Disease Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Biomarker of Disease Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Biomarker of Disease Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Biomarker of Disease Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Biomarker of Disease Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Biomarker of Disease Consumption Value by Type (2019-2030)
  • 6.2 North America Biomarker of Disease Market Size by Application (2019-2030)
  • 6.3 North America Biomarker of Disease Market Size by Country
    • 6.3.1 North America Biomarker of Disease Consumption Value by Country (2019-2030)
    • 6.3.2 United States Biomarker of Disease Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Biomarker of Disease Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Biomarker of Disease Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Biomarker of Disease Consumption Value by Type (2019-2030)
  • 7.2 Europe Biomarker of Disease Consumption Value by Application (2019-2030)
  • 7.3 Europe Biomarker of Disease Market Size by Country
    • 7.3.1 Europe Biomarker of Disease Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Biomarker of Disease Market Size and Forecast (2019-2030)
    • 7.3.3 France Biomarker of Disease Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Biomarker of Disease Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Biomarker of Disease Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Biomarker of Disease Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Biomarker of Disease Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Biomarker of Disease Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Biomarker of Disease Market Size by Region
    • 8.3.1 Asia-Pacific Biomarker of Disease Consumption Value by Region (2019-2030)
    • 8.3.2 China Biomarker of Disease Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Biomarker of Disease Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Biomarker of Disease Market Size and Forecast (2019-2030)
    • 8.3.5 India Biomarker of Disease Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Biomarker of Disease Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Biomarker of Disease Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Biomarker of Disease Consumption Value by Type (2019-2030)
  • 9.2 South America Biomarker of Disease Consumption Value by Application (2019-2030)
  • 9.3 South America Biomarker of Disease Market Size by Country
    • 9.3.1 South America Biomarker of Disease Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Biomarker of Disease Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Biomarker of Disease Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Biomarker of Disease Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Biomarker of Disease Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Biomarker of Disease Market Size by Country
    • 10.3.1 Middle East & Africa Biomarker of Disease Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Biomarker of Disease Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Biomarker of Disease Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Biomarker of Disease Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Biomarker of Disease Market Drivers
  • 11.2 Biomarker of Disease Market Restraints
  • 11.3 Biomarker of Disease Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Biomarker of Disease Industry Chain
  • 12.2 Biomarker of Disease Upstream Analysis
  • 12.3 Biomarker of Disease Midstream Analysis
  • 12.4 Biomarker of Disease Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Biomarker of Disease. Industry analysis & Market Report on Biomarker of Disease is a syndicated market report, published as Global Biomarker of Disease Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Biomarker of Disease market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,780.52
    		4,170.78
    		5,561.04
    		3,358.20
    		5,037.30
    		6,716.40
    		547,160.40
    		820,740.60
    		1,094,320.80
    		298,270.80
    		447,406.20
    		596,541.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo